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Clinical impact of fractional flow reserve versus angiography for gui-
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Background: True small vessels are supplying small myocardial territories
therefore functional significance of correspondent lesions is questionable.
Moreover, percutaneous coronary intervention (PCI) of not-functional small
vessel lesions might be associated with worse clinical outcome. The aim of
this study was to assess the clinical impact of Fractional Flow Reserve (FFR)
versus Angiography for guiding PCI in the treatment of small coronary vessel
lesions.
Methods and Results: From January 2004 to December 2008, all patients
treated with PCI for stable or unstable angina in a native small coronary vessel
(defined by a reference vessel diameter < 3mm) were enrolled. Patients were
divided into two groups according to type of strategy used: Angio vs. FFR-
guided PCI. A total of 717 patients were enrolled (495 Angio-guided PCI, 222
FFR-guided PCI). Clinical follow up was obtained in 97.5% (median follow-
up 3.3±1.3 years). The proportion of patients treated with drug-eluting stent
was similar in both groups. At five years, patients treated with FFR-guided
PCI showed significantly lower death or non-fatal myocardial infarction (MI)
(HR 0.41, 95%CI 0.23-0.75, p=0,004), target vessel revascularization (TVR)
(HR 0.52, 95%CI 0.32-0.83, p=0.006) and major adverse cardiac events
(MACE) (HR 0.46, 95%CI 0.31-0.68, p<0.001). No significant differences
were observed between the two groups as to death and myocardial infarction.
Costs of procedures were also reduced in FFR guided strategy (p<0.0001).
Conclusions: FFR-guided PCI is more effective than Angio-guided PCI in
reducing death or non-fatal MI, TVR and MACE and in patients with small
vessel disease.
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Purpose: Our objective was to assess the long term prognosis impact of
LVEF in a contemporary large cohort of pts with established CAD.
Methods: Among 834 consecutive male pts hospitalized in 2001-2004 for
coronary artery disease, LVEF was assessed in 716 pts. LVEF >0.50 was con-
sidered as normal. Values between 0.50 and 0.35 were considered as low, and
LVEF 0.35 was considered as very low. The median follow-up was 7.17
years. Total mortality was predicted with a Cox proportional hazard model.
Results: Mean age (SD) was 60.2 (8.1), 144 pts (18.4%) were diabetic,
155 pts (19.8%) were smokers, mean blood pressure was 139 (20)/84 (11)
mmHg and median heart rate was 61 bpm [Interquatile range (IQR)] [57-70].
Mean Cockcroft-Gault creatinine clearance was 87 ml/min and 11 pts (1.4%)
had a severe chronic renal failure (lower than 30 ml/min). 88.5% were on anti-
platelet therapy, 75.2% on beta-blocker, 66% on statin therapy and 54.8% on
ACE inhibitors or ARB. The sample comprised 413 (57%) pts with normal
LVEF and 308 (43%) with systolic dysfunction (203 (65.9%) pts had a low
and 105 (34.1%) a very low LVEF). Among the 308 pts with systolic dysfunc-
tion, 78.2% were treated with beta blockers and 72.7% with ACE inhibitors or
ARB. The cumulative seven-year total mortality rate was 18.5% (8.6% in the
normal LEVF group whereas it was 23.6% and 47.6% in the low and the very
low LVEF groups, respectively, (p<0.001). After multivariate adjustment for
age, diabetes, tobacco consumption, heart rate, duration of CAD, ankle-bra-
chial index, history of chronic obstructive pulmonary disease or stroke, statin
therapy and coronary revascularization, hazard ratio for of all-cause death was
2.51 (95% CI [1.59; 3.95] p<0.001) for low LVEF and 4.27 ([2.67; 6.84]
p<0.001) for very low LVEF compared to pts with normal LVEF.
Conclusion: Left ventricular ejection fraction remains a strong and inde-
pendent long term predictor factor for all-cause death in CAD, even in a con-
temporary well treated cohort.
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Purpose: Early impairment of LV function using Brain Natriuretic Peptide
(BNP) level has been proposed to stratify asymptomatic Aortic Stenosis (AS)
with a poor outcome. Recent studies suggest that longitudinal global strain by
speckle tracking may be useful to detect early stages of LV dysfunction. The
purpose of the present study is to establish the relationship between longitu-
dinal global strain and NT-proBNP value in the setting of asymptomatic AS.
Methods: The study included 128 patients (74+/–12 years; 59% men,) with
moderate to severe AS (1.0±0.3 cm2) with preserved LVEF (>50%, 64+/–5%).
Longitudinal global strain by 2D speckle tracking was compared to the pres-
ence of symptoms and plasmatic NT-proBNP measurement.
Results: On the whole, NT-proBNP averaged 723±1097 pg/mL and was
higher in symptomatic patients (1203±1350 vs. 325±484 pg/mL, p<0.0001).
However, elevated NT-proBNP level (>500 pg/mL) was observed in 18%
asymptomatic patients (n=14/79). In asymptomatic patients, no difference was
found for LVEF (65±5 vs. 63±4%), peak aortic jet velocity (3.5±0.8 vs.
3.9±0.9 m.s-1) or aortic valve area (1.1±0.4 vs. 1.0±0.4 cm²) between patients
with and without elevated NTproBNP. Importantly, global longitudinal strain
was significantly impaired in asymptomatic patients with elevated NT-
proBNP (–17±4% vs. –19±3%, p<0.05) and did not differ from symptomatic
patients (–17±3%).
Conclusion: Impaired longitudinal global strain in asymptomatic aortic
stenosis is associated with an increase in NTproBNP level and may be used to
better identify falsely asymptomatic patients.
286
Long-term impact of repeat percutaneous mitral commissurotomy on
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Purpose: Percutaneous mitral commissurotomy (PMC) can be repeated in
case of mitral restenosis. However, the impact of repeat PMC on the possi-
bility of deferring mitral surgery has not been specifically studied. We there-
fore analysed long-term follow-up (FU) after PMC, comparing survival
without re-intervention (surgery or repeat PMC) to survival without surgery
alone.
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Methods: We report the 20-year FU of 912 patients (pts) who had good
immediate results (IR) of PMC (valve area -1.5cm² with mitral regurgitation
-2/4). Mean age was 48±13 yrs, 251 pts (27%) had calcified valves.
Results: During a mean FU of 12 years, 351 pts (38%) required a repeat
intervention on the mitral valve. Surgery was performed in 266 pts (76%). A
repeat PMC could be performed in 85 pts (24%) a mean of 10±4 years after
the first PMC, with good IR in 80 pts (94%).
Survival without re-intervention was 38±2% at 20 years. When considering
surgery alone, the corresponding rate increased to 46±2% at 20 years. In the
504 pts aged <50 years at their first PMC, 20-year rates were 45±3% for sur-
vival without re-intervention and 57±3% for survival without surgery (Figure).
Conclusion: After successful PMC 1) Re-intervention is frequently needed
during long-term FU 2) Repeat PMC can be performed in one out of 4 pts
needing re-intervention. 3) Surgery can thus be further postponed in a substan-
tial number of patients. 4) The favourable impact of repeat PMC is particu-
larly marked in pts aged <50 years, enabling more than half of them to remain
free from surgery 20 years after initial PMC.
287
Early repolarization syndrome: valsalva maneuver in familial screening 
Jean-Baptiste Gourraud [Orateur] (1), Frédéric Sacher (2), Richard Redon
(3), Jean-Jacques Schott (3), Pascal Chavernac (4), Hervé Lemarec (1),
Philippe Mabo (5), Michel Haïssaguerre (2), Vincent Probst (1)
(1) CHU Nantes, HGRL, Institut du Thorax, Nantes, France – (2) CHU
Bordeaux, Cardiologie, Bordeaux, France – (3) CHU Nantes, Unité
Inserm U915, IRT UN, Institut du Thorax, Nantes, France – (4) CHR Cas-
tres-Mazamet, Castres, France – (5) CHU Rennes, Cardiologie,Rennes,
France
Introduction: Early repolarization (ER) has been recently linked with
idiopathic ventricular fibrillation. In spite of a frequent familial past history of
SCD, ER identification in relatives is limited by variability of the ER over the
time and with the variation of autonomic tone and heart rate. The aim of the
study was to test the ability of valsalva maneuver (VM) to identify larges fam-
ilies affected by early repolarization syndrome (ERS).
Methods: We have screened relatives of 2 families in which SCD occurred
with ERS. Patients were considered to be affected in the presence of a positive
deflection on the S wave in two consecutive leads and at least a 1 mm ampli-
tude above baseline. A VM was performed in relatives to increase or reveal
ER. Comparison between heart rate and J wave amplitude before and after
VM was performed with a paired Student's t-test.
Results: VM was performed for 80 relatives. It increased ER amplitude in
17/20 (85%) affected patients and revealed ER in 17/60 (28%) patients unaf-
fected at rest. VM succeeded in unmasking pattern for 5/11 (45%) expected
carrier of ER previously considered as unaffected. Heart rate at rest was
75±13 bpm and decreased of 3,9±7,9 bpm (p<0,001) during the test without
any difference between groups.
In the first family, 4 SCD occured whose one with an ER pattern. We iden-
tified 25 other ER out of 82 available ECG (prevalence 34%).
In the second family, 4 SCD occurred whose one with an ER pattern. We
identified 17 other ER out of 29 available ECG (prevalence 58%).
In those families, ER is transmitted with an autosomal dominant trait
through respectively 5 and 4 generations.
Conclusion: Malignant forms of ER can be transmitted as an autosomal
dominant trait in large families. VM could be helpful to unmask ER for
familial screening of relatives. Further investigations are required to assess
prognosis of VM.
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Purpose: Recent trials have provided worrying safety data on certain oral
hypoglycemic drugs. The aim of this study was to assess 14-year risk of all-
cause mortality according to hypoglycemic drug exposure at baseline, in a
general population.
Methods: Our analysis was based on the Third French MONICA survey
(1995-1996). Participants aged 35-64 were randomly recruited from the gen-
eral population of three French areas. Vital status was obtained 14 years after
inclusion, and assessment of determinants of mortality was based on multi-
variable Cox modelling.
Results: There were 3403 participants and 272 deaths over the 14-year
period. At baseline, there were 3220 (95%) non-diabetic subjects, 48 (1%)
untreated diabetics and 135 (4%) diabetics with hypoglycemic drug treatment
(metformin alone (30%), sulfonylurea alone or in combination with other
hypoglycemic drugs except insulin (48%), insulin alone or in combination
with other hypoglycemic drugs except sulfonylurea (13%), other treatments
(9%)). Death rate was 7%, 23% and 21% in non-diabetic subjects, untreated
diabetics and diabetics with hypoglycemic drugs, respectively. A multivariate
analysis was performed with adjustment for duration of diabetes, history of
diabetes complications or severe chronic disease, and living area, age, gender,
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